Annals of Hepatology

Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease Shan Hong; Yiwei Hao; Lei Sun; Ping Li; Junru Yang; Fuyang Zhang; Lingling He; Jing Zhang; Hongshan Wei;

Psoriasis and steatotic liver disease: Are PNPLA3 and TM6SF2 polymorphisms suitable for the hepato-dermal axis hypothesis? Luciana Agoglia; Ana Carolina Cardoso; Lívia Barbosa; Cecília Schubert Xavier Lagalhard Victer; Sueli Carneiro; Paulo Henrique Condeixa de França; Maria Chiara Chindamo; Cristiane Alves Villela-Nogueira;

Updated recommendations for the management of metabolic dysfunction¿associated steatotic liver disease (MASLD) by the Latin American working group Luis Antonio Diaz; Juan Pablo Arab; Francisco Idalsoaga; Javiera Perelli; Javier Vega; Melisa Dirchwolf; Javiera Carreño; Bárbara Samith; Cynthia Valério; Rodrigo Oliveira Moreira; Mónica Acevedo; Javier Brahm; Nelia Hernández; Adrian Gadano; Claudia P. Oliveira; Marco Arrese; Graciela Castro-Narro; Mario G. Pessoa;